AgaMatrix and Glytec said today that the companies are partnering to develop a cloud-based diabetes management platform to optimize clinical access to glucose data and insulin titration support.

The platform will combine AgaMatrix’s FDA-cleared Jazz Wireless 2 Bluetooth blood glucose monitoring tech with Glytec’s eGlycemic Management System, according to the companies.

Get the full story at our sister site, Drug Delivery Business News.